News & Events about Gossamer Bio Inc.
NEW YORK, Jan. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Gossamer Bio, Inc. (Gossamer or the Company) (NASDAQ:GOSS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
NEW YORK, Dec. 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Gossamer Bio, Inc. (Gossamer or the Company) (NASDAQ:GOSS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PR Newswire NEW YORK, Dec. 19, 2022 NEW YORK, Dec. 19, 2022 /PRNewswire...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PR Newswire NEW YORK, Dec. 13, 2022 NEW YORK, Dec. 13, 2022 /PRNewswire...
Thinking about buying stock in Summit Therapeutics, Gossamer Bio, Xpeng, BioNano Genomics, or Canopy Growth Corp? Thinking about buying stock in Summit Therapeutics, Gossamer Bio, Xpeng, BioNano Genomics, or Canopy Growth Corp? PR Newswire NEW YORK, Dec. 6, 2022 NEW YORK, Dec. 6, 2022 /PRNewswire...